Table 3 Antibiotic resistance in non-ESBL E. coli
Antibiotics | Sensitive | Intermediate | Resistant |
|---|---|---|---|
Ampicillin | 2 (9.5%) | 0 (0%) | 5 (23.8%) |
Gentamicin | 13 (61.9%) | 1 (4.8%) | 3 (14.3%) |
Piperacillin/Tazobactam | 10 (47.6%) | 2 (9.6%) | 5 (23.8%) |
Cefepime | 4 (19%) | 0 (0%) | 5 (23.8%) |
Cefotaxime | 3 (14.3%) | 0 (0%) | 7 (33.3%) |
Ceftazidime | 2 (9.5%) | 1 (4.8%) | 6 (28.6%) |
Ciprofloxacin | 6 (28.6%) | 0 (0%) | 9 (42.9%) |
Meropenem | 12 (57.1%) | 0 (0%) | 2 (9.5%) |
Trimethoprim/sulfamethoxazole | 5 (23.8%) | 0 (0%) | 8 (38.1%) |
Nitrofurantoin | 13 (61.9%) | 0 (0%) | 2 (9.5%) |
Clavulanic acid + Ceftazidime | 0 (0%) | 0 (0%) | 0 (0%) |
Clavulanic acid + Cefotaxime | 1 (4.8%) | 0 (0%) | 0 (0%) |
Amikacin | 6 (28.6%) | 0 (0%) | 0 (0%) |
Oxacillin | 3 (14.3%) | 0 (0%) | 0 (0%) |
Norfloxacin | 2 (9.5%) | 0 (0%) | 2 (9.5%) |
Clindamycin | 1 (4.8%) | 0 (0%) | 0 (0%) |